Parkinson Disease Clinical Trial
Official title:
CEE PMSS (Central Eastern European Post-Marketing Surveillance Study) First Presentation of Mirapexin in Parkinson Patients
| NCT number | NCT00802178 |
| Other study ID # | 248.613 |
| Secondary ID | |
| Status | Completed |
| Phase | N/A |
| First received | December 3, 2008 |
| Last updated | March 14, 2014 |
| Start date | February 2006 |
In this study information is gathered about the treatment of Parkinson patients who present themselves in a neurological practice for the first time
| Status | Completed |
| Enrollment | 2448 |
| Est. completion date | |
| Est. primary completion date | September 2007 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - Parkinson Disease patients presenting to neurologist for first time Exclusion Criteria: - Hypersensitivity to the active substance or to any of the excipients |
Observational Model: Cohort, Time Perspective: Prospective
| Country | Name | City | State |
|---|---|---|---|
| Croatia | Boehringer Ingelheim Investigational Site | Šibenik | |
| Croatia | Boehringer Ingelheim Investigational Site | Bjelovar | |
| Croatia | Boehringer Ingelheim Investigational Site | Dubrovnik | |
| Croatia | Boehringer Ingelheim Investigational Site | Gospic | |
| Croatia | Boehringer Ingelheim Investigational Site | Karlovac | |
| Croatia | Boehringer Ingelheim Investigational Site | Požega | |
| Croatia | Boehringer Ingelheim Investigational Site | Pula | |
| Croatia | Boehringer Ingelheim Investigational Site | Rijeka | |
| Croatia | Boehringer Ingelheim Investigational Site | Sisak | |
| Croatia | Boehringer Ingelheim Investigational Site | Split | |
| Croatia | Boehringer Ingelheim Investigational Site | Zabok | |
| Czech Republic | Boehringer Ingelheim Investigational Site 1 | Ždár n. Sázavou | |
| Czech Republic | Boehringer Ingelheim Investigational Site 2 | Ždár n. Sázavou | |
| Czech Republic | Boehringer Ingelheim Investigational Site | Blansko | |
| Czech Republic | Boehringer Ingelheim Investigational Site | Brandýs n. Orlicí | |
| Czech Republic | Boehringer Ingelheim Investigational Site 1 | Brno | |
| Czech Republic | Boehringer Ingelheim Investigational Site 2 | Brno | |
| Czech Republic | Boehringer Ingelheim Investigational Site | Bystrice n. Pernštejnem | |
| Czech Republic | Boehringer Ingelheim Investigational Site | Cernožice | |
| Czech Republic | Boehringer Ingelheim Investigational Site 1 | Ceská Lípa | |
| Czech Republic | Boehringer Ingelheim Investigational Site 2 | Ceská Lípa | |
| Czech Republic | Boehringer Ingelheim Investigational Site 1 | Ceské Budejovice | |
| Czech Republic | Boehringer Ingelheim Investigational Site 2 | Ceské Budejovice | |
| Czech Republic | Boehringer Ingelheim Investigational Site 3 | Ceské Budejovice | |
| Czech Republic | Boehringer Ingelheim Investigational Site 4 | Ceské Budejovice | |
| Czech Republic | Boehringer Ingelheim Investigational Site | Ceský Krumlov | |
| Czech Republic | Boehringer Ingelheim Investigational Site 1 | Cheb | |
| Czech Republic | Boehringer Ingelheim Investigational Site 2 | Cheb | |
| Czech Republic | Boehringer Ingelheim Investigational Site 3 | Cheb | |
| Czech Republic | Boehringer Ingelheim Investigational Site 1 | Chomutov | |
| Czech Republic | Boehringer Ingelheim Investigational Site 2 | Chomutov | |
| Czech Republic | Boehringer Ingelheim Investigational Site | Frýdek - Místek | |
| Czech Republic | Boehringer Ingelheim Investigational Site | Havíov | |
| Czech Republic | Boehringer Ingelheim Investigational Site | Hodonín | |
| Czech Republic | Boehringer Ingelheim Investigational Site | Holesov | |
| Czech Republic | Boehringer Ingelheim Investigational Site | Hradec Králové | |
| Czech Republic | Boehringer Ingelheim Investigational Site | Jablonec n. Nisou | |
| Czech Republic | Boehringer Ingelheim Investigational Site | Jicín | |
| Czech Republic | Boehringer Ingelheim Investigational Site | Jilemnice | |
| Czech Republic | Boehringer Ingelheim Investigational Site 1 | Karlovy Vary | |
| Czech Republic | Boehringer Ingelheim Investigational Site 2 | Karlovy Vary | |
| Czech Republic | Boehringer Ingelheim Investigational Site | Kladno | |
| Czech Republic | Boehringer Ingelheim Investigational Site | Kolín | |
| Czech Republic | Boehringer Ingelheim Investigational Site 1 | Kromeríz | |
| Czech Republic | Boehringer Ingelheim Investigational Site 2 | Kromeríz | |
| Czech Republic | Boehringer Ingelheim Investigational Site 1 | Kyjov | |
| Czech Republic | Boehringer Ingelheim Investigational Site 2 | Kyjov | |
| Czech Republic | Boehringer Ingelheim Investigational Site 1 | Liberec | |
| Czech Republic | Boehringer Ingelheim Investigational Site 2 | Liberec | |
| Czech Republic | Boehringer Ingelheim Investigational Site 3 | Liberec | |
| Czech Republic | Boehringer Ingelheim Investigational Site | Lipník nad Becvou | |
| Czech Republic | Boehringer Ingelheim Investigational Site 1 | Litomerice | |
| Czech Republic | Boehringer Ingelheim Investigational Site 2 | Litomerice | |
| Czech Republic | Boehringer Ingelheim Investigational Site 1 | Litomysl | |
| Czech Republic | Boehringer Ingelheim Investigational Site 2 | Litomysl | |
| Czech Republic | Boehringer Ingelheim Investigational Site | Litovel | |
| Czech Republic | Boehringer Ingelheim Investigational Site | Mladá Boleslav | |
| Czech Republic | Boehringer Ingelheim Investigational Site | Moravské Budejovice | |
| Czech Republic | Boehringer Ingelheim Investigational Site | Moravský Krumlov | |
| Czech Republic | Boehringer Ingelheim Investigational Site | Náchod | |
| Czech Republic | Boehringer Ingelheim Investigational Site 1 | Olomouc | |
| Czech Republic | Boehringer Ingelheim Investigational Site 2 | Olomouc | |
| Czech Republic | Boehringer Ingelheim Investigational Site 3 | Olomouc | |
| Czech Republic | Boehringer Ingelheim Investigational Site 4 | Olomouc | |
| Czech Republic | Boehringer Ingelheim Investigational Site 5 | Olomouc | |
| Czech Republic | Boehringer Ingelheim Investigational Site 6 | Olomouc | |
| Czech Republic | Boehringer Ingelheim Investigational Site 7 | Olomouc | |
| Czech Republic | Boehringer Ingelheim Investigational Site | Opava | |
| Czech Republic | Boehringer Ingelheim Investigational Site | Ostrava - Poruba | |
| Czech Republic | Boehringer Ingelheim Investigational Site | Ostrava Pustkovec | |
| Czech Republic | Boehringer Ingelheim Investigational Site | Písek | |
| Czech Republic | Boehringer Ingelheim Investigational Site 1 | Plzen | |
| Czech Republic | Boehringer Ingelheim Investigational Site 2 | Plzen | |
| Czech Republic | Boehringer Ingelheim Investigational Site 3 | Plzen | |
| Czech Republic | Boehringer Ingelheim Investigational Site 4 | Plzen | |
| Czech Republic | Boehringer Ingelheim Investigational Site 5 | Plzen | |
| Czech Republic | Boehringer Ingelheim Investigational Site 6 | Plzen | |
| Czech Republic | Boehringer Ingelheim Investigational Site 7 | Plzen | |
| Czech Republic | Boehringer Ingelheim Investigational Site 1 | Praha | |
| Czech Republic | Boehringer Ingelheim Investigational Site 2 | Praha 2 | |
| Czech Republic | Boehringer Ingelheim Investigational Site 3 | Praha 2 | |
| Czech Republic | Boehringer Ingelheim Investigational Site 4 | Praha 3 | |
| Czech Republic | Boehringer Ingelheim Investigational Site 5 | Praha 3 | |
| Czech Republic | Boehringer Ingelheim Investigational Site 6 | Praha 3 | |
| Czech Republic | Boehringer Ingelheim Investigational Site 10 | Praha 4 | |
| Czech Republic | Boehringer Ingelheim Investigational Site 11 | Praha 4 | |
| Czech Republic | Boehringer Ingelheim Investigational Site 7 | Praha 4 | |
| Czech Republic | Boehringer Ingelheim Investigational Site 8 | Praha 4 | |
| Czech Republic | Boehringer Ingelheim Investigational Site 9 | Praha 4 | |
| Czech Republic | Boehringer Ingelheim Investigational Site 12 | Praha 4 - Kamýk | |
| Czech Republic | Boehringer Ingelheim Investigational Site 13 | Praha 5 | |
| Czech Republic | Boehringer Ingelheim Investigational Site 14 | Praha 6 | |
| Czech Republic | Boehringer Ingelheim Investigational Site 15 | Praha 6 | |
| Czech Republic | Boehringer Ingelheim Investigational Site 16 | Praha 6 | |
| Czech Republic | Boehringer Ingelheim Investigational Site 17 | Praha 6 | |
| Czech Republic | Boehringer Ingelheim Investigational Site 18 | Praha 6 | |
| Czech Republic | Boehringer Ingelheim Investigational Site 19 | Praha 8 | |
| Czech Republic | Boehringer Ingelheim Investigational Site 20 | Praha 8 | |
| Czech Republic | Boehringer Ingelheim Investigational Site 21 | Praha 9 | |
| Czech Republic | Boehringer Ingelheim Investigational Site | Preštice | |
| Czech Republic | Boehringer Ingelheim Investigational Site | Prerov | |
| Czech Republic | Boehringer Ingelheim Investigational Site 1 | Príbram | |
| Czech Republic | Boehringer Ingelheim Investigational Site 2 | Príbram | |
| Czech Republic | Boehringer Ingelheim Investigational Site | Srubec, Ceské Budejovice | |
| Czech Republic | Boehringer Ingelheim Investigational Site | Stenberk | |
| Czech Republic | Boehringer Ingelheim Investigational Site | Strakonice | |
| Czech Republic | Boehringer Ingelheim Investigational Site | Svitavy | |
| Czech Republic | Boehringer Ingelheim Investigational Site | Teplice | |
| Czech Republic | Boehringer Ingelheim Investigational Site | Trebíc | |
| Czech Republic | Boehringer Ingelheim Investigational Site | Trinec | |
| Czech Republic | Boehringer Ingelheim Investigational Site | Trutnov | |
| Czech Republic | Boehringer Ingelheim Investigational Site | Ústí n. Labem | |
| Czech Republic | Boehringer Ingelheim Investigational Site | Vojnuv Mestec | |
| Czech Republic | Boehringer Ingelheim Investigational Site | Zlín | |
| Czech Republic | Boehringer Ingelheim Investigational Site | Znojmo | |
| Estonia | Boehringer Ingelheim Investigational Site | Kohtla-Järve | |
| Estonia | Boehringer Ingelheim Investigational Site | Pärnu | |
| Estonia | Boehringer Ingelheim Investigational Site | Tallinn | |
| Estonia | Boehringer Ingelheim Investigational Site | Tartu | |
| Hungary | Boehringer Ingelheim Investigational Site | Balassagyarmat | |
| Hungary | Boehringer Ingelheim Investigational Site | Berettyóújfalu | |
| Hungary | Boehringer Ingelheim Investigational Site 1 | Budapest | |
| Hungary | Boehringer Ingelheim Investigational Site 10 | Budapest | |
| Hungary | Boehringer Ingelheim Investigational Site 11 | Budapest | |
| Hungary | Boehringer Ingelheim Investigational Site 12 | Budapest | |
| Hungary | Boehringer Ingelheim Investigational Site 13 | Budapest | |
| Hungary | Boehringer Ingelheim Investigational Site 14 | Budapest | |
| Hungary | Boehringer Ingelheim Investigational Site 15 | Budapest | |
| Hungary | Boehringer Ingelheim Investigational Site 2 | Budapest | |
| Hungary | Boehringer Ingelheim Investigational Site 3 | Budapest | |
| Hungary | Boehringer Ingelheim Investigational Site 4 | Budapest | |
| Hungary | Boehringer Ingelheim Investigational Site 5 | Budapest | |
| Hungary | Boehringer Ingelheim Investigational Site 6 | Budapest | |
| Hungary | Boehringer Ingelheim Investigational Site 7 | Budapest | |
| Hungary | Boehringer Ingelheim Investigational Site 8 | Budapest | |
| Hungary | Boehringer Ingelheim Investigational Site 9 | Budapest | |
| Hungary | Boehringer Ingelheim Investigational Site 1 | Debrecen | |
| Hungary | Boehringer Ingelheim Investigational Site 2 | Debrecen | |
| Hungary | Boehringer Ingelheim Investigational Site | Dunaújváros | |
| Hungary | Boehringer Ingelheim Investigational Site | Eger | |
| Hungary | Boehringer Ingelheim Investigational Site | Esztergom | |
| Hungary | Boehringer Ingelheim Investigational Site | Gyõr | |
| Hungary | Boehringer Ingelheim Investigational Site | Hatvan | |
| Hungary | Boehringer Ingelheim Investigational Site | Kaposvár | |
| Hungary | Boehringer Ingelheim Investigational Site 1 | Kecskemét | |
| Hungary | Boehringer Ingelheim Investigational Site 2 | Kecskemét | |
| Hungary | Boehringer Ingelheim Investigational Site | Kistarcsa | |
| Hungary | Boehringer Ingelheim Investigational Site | Kisvárda | |
| Hungary | Boehringer Ingelheim Investigational Site | Miskolc | |
| Hungary | Boehringer Ingelheim Investigational Site | Nyíregyháza | |
| Hungary | Boehringer Ingelheim Investigational Site 1 | Pécs | |
| Hungary | Boehringer Ingelheim Investigational Site 2 | Pécs | |
| Hungary | Boehringer Ingelheim Investigational Site | Ráckeve | |
| Hungary | Boehringer Ingelheim Investigational Site | Salgótarján | |
| Hungary | Boehringer Ingelheim Investigational Site | Sopron | |
| Hungary | Boehringer Ingelheim Investigational Site | Szekszárd | |
| Hungary | Boehringer Ingelheim Investigational Site | Szentendre | |
| Hungary | Boehringer Ingelheim Investigational Site | Vác | |
| Hungary | Boehringer Ingelheim Investigational Site | Veszprém | |
| Romania | Boehringer Ingelheim Investigational Site | Alba Iulia | |
| Romania | Boehringer Ingelheim Investigational Site | Arad | |
| Romania | Boehringer Ingelheim Investigational Site | Bacau | |
| Romania | Boehringer Ingelheim Investigational Site 1 | Baia Mare | |
| Romania | Boehringer Ingelheim Investigational Site 2 | Baia Mare | |
| Romania | Boehringer Ingelheim Investigational Site | Bistrita | |
| Romania | Boehringer Ingelheim Investigational Site | Brasov | |
| Romania | Boehringer Ingelheim Investigational Site 1 | Bucuresti | |
| Romania | Boehringer Ingelheim Investigational Site 10 | Bucuresti | |
| Romania | Boehringer Ingelheim Investigational Site 11 | Bucuresti | |
| Romania | Boehringer Ingelheim Investigational Site 12 | Bucuresti | |
| Romania | Boehringer Ingelheim Investigational Site 13 | Bucuresti | |
| Romania | Boehringer Ingelheim Investigational Site 14 | Bucuresti | |
| Romania | Boehringer Ingelheim Investigational Site 15 | Bucuresti | |
| Romania | Boehringer Ingelheim Investigational Site 16 | Bucuresti | |
| Romania | Boehringer Ingelheim Investigational Site 17 | Bucuresti | |
| Romania | Boehringer Ingelheim Investigational Site 18 | Bucuresti | |
| Romania | Boehringer Ingelheim Investigational Site 19 | Bucuresti | |
| Romania | Boehringer Ingelheim Investigational Site 2 | Bucuresti | |
| Romania | Boehringer Ingelheim Investigational Site 20 | Bucuresti | |
| Romania | Boehringer Ingelheim Investigational Site 21 | Bucuresti | |
| Romania | Boehringer Ingelheim Investigational Site 3 | Bucuresti | |
| Romania | Boehringer Ingelheim Investigational Site 4 | Bucuresti | |
| Romania | Boehringer Ingelheim Investigational Site 5 | Bucuresti | |
| Romania | Boehringer Ingelheim Investigational Site 6 | Bucuresti | |
| Romania | Boehringer Ingelheim Investigational Site 7 | Bucuresti | |
| Romania | Boehringer Ingelheim Investigational Site 8 | Bucuresti | |
| Romania | Boehringer Ingelheim Investigational Site 9 | Bucuresti | |
| Romania | Boehringer Ingelheim Investigational Site 1 | Buzau | |
| Romania | Boehringer Ingelheim Investigational Site 2 | Buzau | |
| Romania | Boehringer Ingelheim Investigational Site 3 | Buzau | |
| Romania | Boehringer Ingelheim Investigational Site | Campina | |
| Romania | Boehringer Ingelheim Investigational Site | Campulung | |
| Romania | Boehringer Ingelheim Investigational Site 1 | Cluj | |
| Romania | Boehringer Ingelheim Investigational Site 2 | Cluj | |
| Romania | Boehringer Ingelheim Investigational Site 3 | Cluj | |
| Romania | Boehringer Ingelheim Investigational Site 1 | Constanta | |
| Romania | Boehringer Ingelheim Investigational Site 2 | Constanta | |
| Romania | Boehringer Ingelheim Investigational Site 3 | Constanta | |
| Romania | Boehringer Ingelheim Investigational Site 1 | Craiova | |
| Romania | Boehringer Ingelheim Investigational Site 2 | Craiova | |
| Romania | Boehringer Ingelheim Investigational Site 3 | Craiova | |
| Romania | Boehringer Ingelheim Investigational Site 1 | Curtea de Arges | |
| Romania | Boehringer Ingelheim Investigational Site 2 | Curtea de Arges | |
| Romania | Boehringer Ingelheim Investigational Site | Deva | |
| Romania | Boehringer Ingelheim Investigational Site 1 | Galati | |
| Romania | Boehringer Ingelheim Investigational Site 2 | Galati | |
| Romania | Boehringer Ingelheim Investigational Site | Giurgiu | |
| Romania | Boehringer Ingelheim Investigational Site 1 | Iasi | |
| Romania | Boehringer Ingelheim Investigational Site 2 | Iasi | |
| Romania | Boehringer Ingelheim Investigational Site 3 | Iasi | |
| Romania | Boehringer Ingelheim Investigational Site 4 | Iasi | |
| Romania | Boehringer Ingelheim Investigational Site 1 | Oradea | |
| Romania | Boehringer Ingelheim Investigational Site 2 | Oradea | |
| Romania | Boehringer Ingelheim Investigational Site | Petrosani | |
| Romania | Boehringer Ingelheim Investigational Site | Piatra Neamt | |
| Romania | Boehringer Ingelheim Investigational Site 1 | Pitesti | |
| Romania | Boehringer Ingelheim Investigational Site 2 | Pitesti | |
| Romania | Boehringer Ingelheim Investigational Site 1 | Ploiesti | |
| Romania | Boehringer Ingelheim Investigational Site 2 | Ploiesti | |
| Romania | Boehringer Ingelheim Investigational Site 3 | Ploiesti | |
| Romania | Boehringer Ingelheim Investigational Site | Rm Valcea | |
| Romania | Boehringer Ingelheim Investigational Site 1 | Satu Mare | |
| Romania | Boehringer Ingelheim Investigational Site 2 | Satu Mare | |
| Romania | Boehringer Ingelheim Investigational Site | Sibiu | |
| Romania | Boehringer Ingelheim Investigational Site | Slatina | |
| Romania | Boehringer Ingelheim Investigational Site | Slobozia | |
| Romania | Boehringer Ingelheim Investigational Site | Suceava | |
| Romania | Boehringer Ingelheim Investigational Site | Tg Mures | |
| Romania | Boehringer Ingelheim Investigational Site 1 | Timisoara | |
| Romania | Boehringer Ingelheim Investigational Site 2 | Timisoara | |
| Romania | Boehringer Ingelheim Investigational Site 3 | Timisoara | |
| Romania | Boehringer Ingelheim Investigational Site 4 | Timisoara | |
| Romania | Boehringer Ingelheim Investigational Site 5 | Timisoara | |
| Romania | Boehringer Ingelheim Investigational Site | Turnu Severin | |
| Russian Federation | Boehringer Ingelheim Investigational Site 1 | Moscow | |
| Russian Federation | Boehringer Ingelheim Investigational Site 2 | Moscow | |
| Russian Federation | Boehringer Ingelheim Investigational Site 1 | St-Petersburg | |
| Russian Federation | Boehringer Ingelheim Investigational Site 2 | St-Petersburg | |
| Serbia | Boehringer Ingelheim Investigational Site | Arandjelovac | |
| Serbia | Boehringer Ingelheim Investigational Site 1 | Belgrade | |
| Serbia | Boehringer Ingelheim Investigational Site 2 | Belgrade | |
| Serbia | Boehringer Ingelheim Investigational Site 3 | Belgrade | |
| Serbia | Boehringer Ingelheim Investigational Site 4 | Belgrade | |
| Serbia | Boehringer Ingelheim Investigational Site | Kikinda | |
| Serbia | Boehringer Ingelheim Investigational Site | Knjazevac | |
| Serbia | Boehringer Ingelheim Investigational Site | Kragujevac | |
| Serbia | Boehringer Ingelheim Investigational Site | Krusevac | |
| Serbia | Boehringer Ingelheim Investigational Site | Loznica | |
| Serbia | Boehringer Ingelheim Investigational Site | Negotin | |
| Serbia | Boehringer Ingelheim Investigational Site | Nis | |
| Serbia | Boehringer Ingelheim Investigational Site | Novi Sad | |
| Serbia | Boehringer Ingelheim Investigational Site | Sombor | |
| Serbia | Boehringer Ingelheim Investigational Site | Sremska Mitrovica | |
| Serbia | Boehringer Ingelheim Investigational Site | Subotica | |
| Serbia | Boehringer Ingelheim Investigational Site | Vranje | |
| Serbia | Boehringer Ingelheim Investigational Site | Zajecar | |
| Slovakia | Boehringer Ingelheim Investigational Site | Bánovce n. Bebravou | |
| Slovakia | Boehringer Ingelheim Investigational Site 1 | Banská Bystrica | |
| Slovakia | Boehringer Ingelheim Investigational Site 2 | Banská Bystrica | |
| Slovakia | Boehringer Ingelheim Investigational Site 3 | Banská Bystrica | |
| Slovakia | Boehringer Ingelheim Investigational Site 1 | Bratislava | |
| Slovakia | Boehringer Ingelheim Investigational Site 2 | Bratislava | |
| Slovakia | Boehringer Ingelheim Investigational Site 3 | Bratislava | |
| Slovakia | Boehringer Ingelheim Investigational Site 4 | Bratislava | |
| Slovakia | Boehringer Ingelheim Investigational Site 5 | Bratislava | |
| Slovakia | Boehringer Ingelheim Investigational Site | Dolný Kubín | |
| Slovakia | Boehringer Ingelheim Investigational Site | Galanta | |
| Slovakia | Boehringer Ingelheim Investigational Site | Komárno | |
| Slovakia | Boehringer Ingelheim Investigational Site 1 | Kosice | |
| Slovakia | Boehringer Ingelheim Investigational Site 2 | Kosice | |
| Slovakia | Boehringer Ingelheim Investigational Site 3 | Kosice | |
| Slovakia | Boehringer Ingelheim Investigational Site 4 | Kosice | |
| Slovakia | Boehringer Ingelheim Investigational Site 5 | Kosice- Saca | |
| Slovakia | Boehringer Ingelheim Investigational Site | Levice | |
| Slovakia | Boehringer Ingelheim Investigational Site | Liptovský Mikulás | |
| Slovakia | Boehringer Ingelheim Investigational Site | Martin | |
| Slovakia | Boehringer Ingelheim Investigational Site | Myjava | |
| Slovakia | Boehringer Ingelheim Investigational Site 1 | Nitra | |
| Slovakia | Boehringer Ingelheim Investigational Site 2 | Nitra | |
| Slovakia | Boehringer Ingelheim Investigational Site | Nováky | |
| Slovakia | Boehringer Ingelheim Investigational Site | Povazská Bystrica | |
| Slovakia | Boehringer Ingelheim Investigational Site 1 | Presov | |
| Slovakia | Boehringer Ingelheim Investigational Site 2 | Presov | |
| Slovakia | Boehringer Ingelheim Investigational Site | Prievidza | |
| Slovakia | Boehringer Ingelheim Investigational Site | Rimavská Sobota | |
| Slovakia | Boehringer Ingelheim Investigational Site | Roz?ava | |
| Slovakia | Boehringer Ingelheim Investigational Site | Ruzomberok | |
| Slovakia | Boehringer Ingelheim Investigational Site | Skalica | |
| Slovakia | Boehringer Ingelheim Investigational Site | Sliac | |
| Slovakia | Boehringer Ingelheim Investigational Site | Snina | |
| Slovakia | Boehringer Ingelheim Investigational Site 2 | Stará ?ubov?a | |
| Slovakia | Boehringer Ingelheim Investigational Site 1 | Stará Lubovna | |
| Slovakia | Boehringer Ingelheim Investigational Site | Surany | |
| Slovakia | Boehringer Ingelheim Investigational Site | Topolcany | |
| Slovakia | Boehringer Ingelheim Investigational Site 1 | Trebisov | |
| Slovakia | Boehringer Ingelheim Investigational Site 2 | Trebisov | |
| Slovakia | Boehringer Ingelheim Investigational Site | Trnava | |
| Slovakia | Boehringer Ingelheim Investigational Site | Trstená | |
| Slovakia | Boehringer Ingelheim Investigational Site | Vranov nad Toplou | |
| Slovakia | Boehringer Ingelheim Investigational Site 1 | Zilina | |
| Slovakia | Boehringer Ingelheim Investigational Site 2 | Zilina | |
| Slovenia | Boehringer ingelheim Investigational Site 1 | Ljubljana | |
| Slovenia | Boehringer ingelheim Investigational Site 2 | Ljubljana | |
| Slovenia | Boehringer ingelheim Investigational Site 3 | Ljubljana | |
| Slovenia | Boehringer ingelheim Investigational Site 4 | Ljubljana | |
| Slovenia | Boehringer ingelheim Investigational Site 5 | Ljubljana | |
| Slovenia | Boehringer ingelheim Investigational Site 1 | Maribor | |
| Slovenia | Boehringer ingelheim Investigational Site 2 | Maribor | |
| Slovenia | Boehringer ingelheim Investigational Site 3 | Maribor | |
| Slovenia | Boehringer ingelheim Investigational Site 4 | Maribor | |
| Slovenia | Boehringer ingelheim Investigational Site 1 | Sempeter pri Gorici |
| Lead Sponsor | Collaborator |
|---|---|
| Boehringer Ingelheim |
Croatia, Czech Republic, Estonia, Hungary, Romania, Russian Federation, Serbia, Slovakia, Slovenia,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Number of De-novo Patients in Whom Monotherapy With Mirapexin® Could be Successfully Initiated | Successful initiation was defined as a clinical assessment of efficacy by the neurologist rated at least as "good" on a 4 point scale after 4-8 weeks Mirapexin® treatment, where:1 = very good; 2 = good; 3 = moderate; and 4 = poor. De-novo patients were identified by: those who were referred: - if 'Reason for Referral' = 'initiation of therapy' or for 'diagnostic reason' and for those not referred: - if initial pharmacotherapy = 'Mirapexin® monotherapy' (i.e., no other anti Parkinson Disease (PD) therapy) |
4 - 8 weeks | No |
| Secondary | Change From Baseline in UPDRS (Unified Parkinson's Disease Rating Scale) Part I | Change in UPDRS Part I score from baseline to final visit. The score ranging from 0-16 (0= no disability, 16= maximum disability) | Baseline and 4 to 8 weeks | No |
| Secondary | Change From Baseline in UPDRS Part III | Change in UPDRS Part III score from baseline to final visit. Score ranging from 0 - 108 (0= no disability, 108 = worst disability). | Baseline and 4 - 8 weeks | No |
| Secondary | Global Clinical Assessments of Efficacy of Mirapexin® for All Patients | Successful initiation was defined as a clinical assessment of efficacy by the neurologist rated at least as "good" on a 4 point scale after 4-8 weeks Mirapexin® treatment, where:1 = very good; 2 = good; 3 = moderate; and 4 = poor. | 4 - 8 weeks | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05415774 -
Combined Deep Brain Stimulation in Parkinson's Disease
|
N/A | |
| Recruiting |
NCT04691661 -
Safety, Tolerability, Pharmacokinetics and Efficacy Study of Radotinib in Parkinson's Disease
|
Phase 2 | |
| Active, not recruiting |
NCT05754086 -
A Multidimensional Study on Articulation Deficits in Parkinsons Disease
|
||
| Completed |
NCT04045925 -
Feasibility Study of the Taïso Practice in Parkinson's Disease
|
N/A | |
| Recruiting |
NCT04194762 -
PARK-FIT. Treadmill vs Cycling in Parkinson´s Disease. Definition of the Most Effective Model in Gait Reeducation
|
N/A | |
| Completed |
NCT02705755 -
TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)
|
Phase 2 | |
| Terminated |
NCT03052712 -
Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies
|
N/A | |
| Recruiting |
NCT05830253 -
Free-living Monitoring of Parkinson's Disease Using Smart Objects
|
||
| Recruiting |
NCT03272230 -
Assessment of Apathy in a Real-life Situation, With a Video and Sensors-based System
|
N/A | |
| Recruiting |
NCT06139965 -
Validity and Reliability of the Turkish Version of the Comprehensive Coordination Scale in Parkinson's Patients
|
||
| Completed |
NCT04580849 -
Telerehabilitation Using a Dance Intervention in People With Parkinson's Disease
|
N/A | |
| Completed |
NCT04477161 -
Effect of Ketone Esters in Parkinson's Disease
|
N/A | |
| Completed |
NCT03980418 -
Evaluation of a Semiconductor Camera for the DaTSCAN™ Exam
|
N/A | |
| Completed |
NCT04942392 -
Digital Dance for People With Parkinson's Disease During the COVID-19 Pandemic
|
N/A | |
| Terminated |
NCT03446833 -
LFP Beta aDBS Feasibility Study
|
N/A | |
| Completed |
NCT03497884 -
Individualized Precise Localization of rTMS on Primary Motor Area
|
N/A | |
| Completed |
NCT05538455 -
Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases
|
N/A | |
| Recruiting |
NCT04997642 -
Parkinson's Disease and Movement Disorders Clinical Database
|
||
| Completed |
NCT04117737 -
A Pilot Study of Virtual Reality and Antigravity Treadmill for Gait Improvement in Parkinson
|
N/A | |
| Recruiting |
NCT03618901 -
Rock Steady Boxing vs. Sensory Attention Focused Exercise
|
N/A |